SURVEY: Understanding the Current Cancer Pharmacy Technician Landscape

The Pharmacy Technician Subcommittee and Research Subcommittee are conducting an education survey to find out the current level of education and training available to pharmacy technicians and the support they receive locally regarding pharmacy counselling on Systemic Anti-Cancer Therapies (SACT) and SACT prescription verification.

Over the past decade, pharmacy technicians’ roles have grown rapidly, and a better understanding of the local education and training infrastructure would help identify gaps or differences in training, as well as improving access to materials for healthcare providers, trainers, and technicians.

This survey also aims to gather information about your current qualifications, your role and responsibilities, and any further education you plan to pursue. The knowledge will contribute to the development of BOPA’s workforce pillar, the job and workforce planning.

Link to the survey – https://forms.office.com/e/qnvz00jQ5F

Results will be shared via BOPA, and your responses will be anonymous.

The term SACT refers to cytotoxic chemotherapy, immunotherapies, targeted therapies, and other pharmacotherapies for treating cancer.

It should take 20 -25 minutes to complete.

Sent on behalf

Pharmacy Technicians Subcommittee and Research Subcommittee

Latest News

By BOPA Committee on 22nd January 2025

NIHR INSIGHT Programme South London Research Masters Studentships 2025/26: Call for applications

NIHR INSIGHT Programme South London Research Masters Studentships 2025/26: Call for applications is now open. For more info click here and/or see flyer below.  

Read article
By BOPA research committee on 22nd January 2025

SURVEY: Examining barriers to pharmacy professionals engaging with research

The Incubator for Pharmacy Professionals is an NIHR-supported initiative dedicated to strengthening research capacity within the pharmacy profession. Despite its critical role as a pillar of professional practice, research remains…

Read article
By BOPA on 20th January 2025

Monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

The Immune-Related Adverse Effects that arise from use of checkpoint inhibitors can be difficult to manage, especially when steroids are not enough. Despite there being guidance about how to manage…

Read article
By BOPA Committee on 20th January 2025

UTIC course has been awarded a FIP Seal

UTIC (Understanding targeted therapies and immunotherapies for cancer) course has been awarded a FIP Seal. This is a joint collaboration between BOPA and ISOPP. The FIP Seal for programmes is…

Read article